MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Correlations Between Clinical Variables And Cerebral Perfusion in Parkinson’s Disease With Mild Cognitive Impairment: A Multi-Delay pcASL Study

    N. Chaurasiya, G. Rathi, V. Mishra (Birmingham, USA)

    Objective: To evaluate whether partial volume–corrected cerebral blood flow (pvCBF), with and without additional spatial smoothing (5 mm), improves detection of perfusion differences and clinical…
  • 2026 International Congress

    Efficacy and Safety of GLP-1 Receptor Agonists in Parkinson’s Disease: A Meta-Analysis Integrating the 96-Week Phase 3 Exenatide Trial Results

    K. Sarhan (Mansoura, Egypt)

    Objective: To evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists in patients with Parkinson’s disease (PD) through an updated systematic review and meta-analysis…
  • 2026 International Congress

    Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

    A. Negida (Richmond, USA)

    Objective: To estimate the temporal ordering of multimodal biomarker abnormality events leading to cognitive impairment in PD using a Disease Event-Based Model (DEBM), incorporating clinical,…
  • 2026 International Congress

    Urate Levels and Risk of Parkinson’s Disease:A Two-Sample Mendelian Randomization Study

    P. Tang, Y. Liu (Xi'an, China)

    Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…
  • 2026 International Congress

    Evaluating Parkinson’s Disease Telehealth in Residential Aged Care

    J. Ponce, E. Pepper, E. Collins (New Lambton Heights, Australia)

    Objective: To evaluate the use, barriers, outcomes, and clinician perspectives of specialist telehealth for Parkinson’s disease (PD) care in residential aged care facilities. Background: Specialist…
  • 2026 International Congress

    Linear-Time RWKV Multimodal Fusion of Smartphone Audio and Wearable Signals for Mild Cognitive Impairment Screening

    D. Hemmerling, JH. Yun, J. Krzywdziak, B. Eljasiak, A. Pruszek, L. Lazarski, M. Grzeszczyk, T. Brzózka, W. Szecówka, W. średniawa, H. Lee, W. Baek, S. Yoon, M. Matuszewski (Krakow, Poland)

    Objective: To evaluate linear-time RWKV-based multimodal fusion for classifying mild cognitive impairment (MCI) from synchronized smartphone audio and consumer wearable signals, and to compare alternative…
  • 2026 International Congress

    Real-World Mobile Voice Classification for Parkinson’s Disease Using Convolutional Neural Networks and Mel-Spectrogram Features

    N. Leabthong, J. Sringean, T. Laosombut, N. Jeh-Voh1, Z. Win, P. Rattanajun, S. Phumphid, C. Anan, J. Meesri, S. Wekhinhiran, O. Phokaewvarangkul, P. Panyakaew, S. Maytharakcheep, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the performance of deep learning approach based on Mel-spectrogram features in classifying PD using two real-world speech tasks - sustained phonation and…
  • 2026 International Congress

    Digital Innovation in Parkinson’s Disease – Governing Care and Managing Autonomy

    B. Schmitz-Luhn (Bonn, Germany)

    Objective: The study analyzes the regulatory implications of digital technologies in Parkinson’s disease, with particular focus on (1) improvement of care and reduction of intensive…
  • 2026 International Congress

    Intestinal Dysbiosis in Parkinson’s Disease: Mechanisms, Clinical Implications, and Therapeutic Perspectives (2015–2025)

    H. Harifi (Kenitra, Morocco)

    Objective: This narrative review aims to consolidate research published from 2015 to 2025 regarding abnormalities in gut microbiota in patients with Parkinson’s disease, emphasizing potential…
  • 2026 International Congress

    Exploring Usability and Feasibility of an Optimised Smartwatch to Monitor Medication Intake in Parkinson’s Disease

    E. Packer, K. Scott, P. Brown, J. Sarvestan, A. Smalley, O. Brugna, N. Ireson, V. Lanfranchi, L. Rochester, A. Yarnall, L. Alcock, M. Peeters, S. Del Din (United Kingdom)

    Objective: Explore usability and feasibility of an optimised smartwatch to monitor medication intake in people with Parkinson’s disease (PwP). Background: Digital health technology (DHT) can…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley